Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Gastroenterology | Family Medicine
 Disease Category: Colon Cancer
Location: United States, NY

Trial Information

A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint

The purpose of this study is to test the use of a new diagnostic test for tumor treatment in a clinical setting. The test looks at the activity of the genes in tumor tissue and compares it to a large database of gene activities in tumor tissues from patients with known disease outcomes. If you agree to take part in this study, a small part of the tumor tissue removed from you surgically will undergo diagnostic testing.

Patient Inclusion Criteria:

  • At least 18 years of age
  • Must have adenocarcinoma of the colon

Patient Exclusion Criteria:

  • Have rectal cancer or prior malignancy
  • Any prior neo-adjuvant therapy
  • Synchronous tumors

Mohammad Ghalib
Einstein-Montefiore Institute for Clinical & Translational Research
Montefiore Medical Center
Department of Oncology
111 East 210th Street
Bronx, NY 10467
Phone: 718-405-8515
Email: MHGHALIB@montefiore.org

View Map

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.